Difference between revisions of "Ramosetron (Iribo)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
m |
||
| Line 3: | Line 3: | ||
==Also known as== | ==Also known as== | ||
| − | *'''Brand names:''' IBset, Iribo, Nasea, Nozia | + | *'''Brand names:''' IBset, Iribo, Irribow, Nasea, Nozia |
[[Category:Drugs]] | [[Category:Drugs]] | ||
| Line 10: | Line 10: | ||
[[Category:Emesis prevention]] | [[Category:Emesis prevention]] | ||
[[Category:Serotonin 5-HT3 antagonists]] | [[Category:Serotonin 5-HT3 antagonists]] | ||
| − | [[Category:PMDA approved | + | [[Category:PMDA approved in 2015]] |
Latest revision as of 01:27, 11 June 2023
Mechanism of action
Serotonin 5-HT3 receptor antagonist with antiemetic properties. No known antineoplastic properties. Not FDA-approved; available in Japan and Southeast Asia.
Also known as
- Brand names: IBset, Iribo, Irribow, Nasea, Nozia